Cargando…
Immunogenicity and Tolerability after Two Doses of Non-Adjuvanted, Whole-Virion Pandemic Influenza A (H1N1) Vaccine in HIV-Infected Individuals
BACKGROUND: During the influenza pandemic of 2009/10, the whole-virion, Vero-cell-derived, inactivated, pandemic influenza A (H1N1) vaccine Celvapan® (Baxter) was used in Austria. Celvapan® is adjuvant-free and was the only such vaccine at that time in Europe. The objective of this observational, no...
Autores principales: | Lagler, Heimo, Grabmeier-Pfistershammer, Katharina, Touzeau-Römer, Veronique, Tobudic, Selma, Ramharter, Michael, Wenisch, Judith, Gualdoni, Guido Andrés, Redlberger-Fritz, Monika, Popow-Kraupp, Theresia, Rieger, Armin, Burgmann, Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357418/ https://www.ncbi.nlm.nih.gov/pubmed/22629330 http://dx.doi.org/10.1371/journal.pone.0036773 |
Ejemplares similares
-
Low immunogenicity of whole virion, verocell-derived, inactivated, pandemic influenza H1N1 vaccine in HIV-infected patients
por: Lagler, H, et al.
Publicado: (2010) -
Performance of the QuickVue Influenza A+B Rapid Test for Pandemic H1N1 (2009) Virus Infection in Adults
por: Poeppl, Wolfgang, et al.
Publicado: (2011) -
Detailed Report on 2014/15 Influenza Virus Characteristics, and Estimates on Influenza Virus Vaccine Effectiveness from Austria’s Sentinel Physician Surveillance Network
por: Redlberger-Fritz, Monika, et al.
Publicado: (2016) -
Low nasal carriage of drug-resistant bacteria among medical students in Vienna
por: Gualdoni, Guido A., et al.
Publicado: (2012) -
Heterogeneity of Circulating Influenza Viruses and Their Impact on Influenza Virus Vaccine Effectiveness During the Influenza Seasons 2016/17 to 2018/19 in Austria
por: Redlberger-Fritz, Monika, et al.
Publicado: (2020)